Yajun Li , Yuqing Zhao , Weihai Wang , Baojie Qi , Yiting Lv , Shujie Wang , Chunsheng Wang
{"title":"Canine adenovirus type 1 induces PANoptosis in canine splenocytes via AIM2 inflammasome activation","authors":"Yajun Li , Yuqing Zhao , Weihai Wang , Baojie Qi , Yiting Lv , Shujie Wang , Chunsheng Wang","doi":"10.1016/j.vetmic.2026.110965","DOIUrl":null,"url":null,"abstract":"<div><div>Canine adenovirus type 1 (CAV-1) is a primary causative agent of infectious hepatitis in canines, posing a significant health threat. Nevertheless, the mechanism by which CAV-1 infection induces a deleterious inflammatory response remains incompletely understood. In this study, two-month-old Beagles were inoculated with a defined dose of CAV-1, and samples were collected from seven organs. Analysis revealed that the expression of AIM2 in primary target organs, the liver and kidney, was not significantly altered. In contrast, AIM2 expression was markedly upregulated in immune organs—specifically the spleen, tonsils, and lymph nodes—where the expression level of the key pyroptotic core protein also increased significantly. Further investigation demonstrated that CAV-1 induced PANoptosis of T cells and B cells in the spleen of infected Beagles. Subsequent <em>in vitro</em> studies using canine splenocytes corroborated these findings and identified that the interaction between CAV-1 double-stranded DNA (dsDNA) and AIM2 initiates PANoptosis. In conclusion, CAV-1 triggers PANoptosis in canine splenocytes by activating the AIM2 inflammasome pathway. Our study reveals the death pathway of canine splenocytes caused by CAV-1 for the first time. These findings provide a foundation for elucidating the mechanism of CAV-1 induced inflammatory response of canine splenocytes.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"316 ","pages":"Article 110965"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113526000969","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Canine adenovirus type 1 (CAV-1) is a primary causative agent of infectious hepatitis in canines, posing a significant health threat. Nevertheless, the mechanism by which CAV-1 infection induces a deleterious inflammatory response remains incompletely understood. In this study, two-month-old Beagles were inoculated with a defined dose of CAV-1, and samples were collected from seven organs. Analysis revealed that the expression of AIM2 in primary target organs, the liver and kidney, was not significantly altered. In contrast, AIM2 expression was markedly upregulated in immune organs—specifically the spleen, tonsils, and lymph nodes—where the expression level of the key pyroptotic core protein also increased significantly. Further investigation demonstrated that CAV-1 induced PANoptosis of T cells and B cells in the spleen of infected Beagles. Subsequent in vitro studies using canine splenocytes corroborated these findings and identified that the interaction between CAV-1 double-stranded DNA (dsDNA) and AIM2 initiates PANoptosis. In conclusion, CAV-1 triggers PANoptosis in canine splenocytes by activating the AIM2 inflammasome pathway. Our study reveals the death pathway of canine splenocytes caused by CAV-1 for the first time. These findings provide a foundation for elucidating the mechanism of CAV-1 induced inflammatory response of canine splenocytes.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.